Hamid Trimech

I am Head of Business Development at ARCALIS Inc., a Japanese CDMO specializing in mRNA vaccines and therapeutics. I grew up in Lyon, France, one of the world's historical centers for vaccine manufacturing, and have been working in vaccine manufacturing and technology transfer for over a decade.

I have worked on more than 15 vaccine programs across France, South Korea, Japan, India, Brazil, Argentina, and Mexico. My experience covers six vaccine technologies: attenuated, inactivated, subunit, recombinant protein, conjugated, and mRNA. I contributed to the delivery of two approved COVID-19 vaccines, one protein-based and one mRNA.

I led the construction of ARCALIS's drug substance manufacturing facility in Japan and managed the technology transfer of a self-amplifying mRNA vaccine from the United States to Japan. Before ARCALIS, I worked at Sanofi Pasteur in the Global Engineering department, managing drug substance manufacturing projects in South America and Asia.

I am fluent in Japanese and have been based in Tokyo for several years. I work comfortably across cultures and am equally at ease on a production floor, in a regulatory meeting, or in a business development context.

I am also the founder of Biomanufacturing Made Simple, a platform where I share knowledge on vaccine manufacturing, and the author of two books on the subject.